The Impact of the COVID-19 Pandemic on Patient Disparities in Long-Term Opioid Therapy

References

1. 1.↵
   National Institute on Drug Abuse. Overdose death rates 2022 [Accessed 2022 Apr 24]. Available at: https://nida.nih.gov/drug-topics/trends-statistics/overdose-death-rates.
2. 2.↵
   1. Khatri UG,
   2. Pizzicato LN,
   3. Viner K,
   4. et al

   . Racial/ethnic disparities in unintentional fatal and nonfatal emergency medical services–attended opioid overdoses during the COVID-19 pandemic in Philadelphia. JAMA Netw Open 2021;4:e2034878-e.

   OpenUrl
3. 3.↵
   1. de Dios C,
   2. Fernandes BS,
   3. Whalen K,
   4. et al

   . Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States. Drug and Alcohol Dependence 2021;229:109176.

   OpenUrl
4. 4.↵
   1. Lee B,
   2. Yang K-C,
   3. Kaminski P,
   4. et al

   . Substitution of nonpharmacologic therapy with opioid Prescribing for pain during the COVID-19 pandemic. JAMA Netw Open 2021;4:e2138453-e.

   OpenUrl
5. 5.↵
   1. Carrillo-de-la-Peña MT,
   2. González-Villar A,
   3. Triñanes Y

   . Effects of the COVID-19 pandemic on chronic pain in Spain: a scoping review. PR9 2021;6:e899

   OpenUrl
6. 6.↵
   1. Choe K,
   2. Zinn E,
   3. Lu K,
   4. Hoang D,
   5. Yang LH

   . Impact of COVID-19 pandemic on chronic pain and opioid use in marginalized populations: a scoping review. Front Public Health 2023;11:1046683.

   OpenUrl
7. 7.↵
   Institute of Medicine Committee on Advancing Pain Research C, Education. The National Academies Collection: Reports funded by National Institutes of Health. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington (DC): National Academies Press (US), National Academy of Sciences 2011.
8. 8.↵
   1. Levy B,
   2. Paulozzi L,
   3. Mack KA,
   4. Jones CM

   . Trends in opioid analgesic–prescribing rates by specialty, US, 2007–2012. American Journal of Preventive Medicine 2015;49:409–13.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Tong ST,
   2. Hochheimer CJ,
   3. Brooks EM,
   4. et al

   . Chronic opioid prescribing in primary care: factors and perspectives. Ann Fam Med 2019;17:200–6.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Dowell D,
    2. Ragan K,
    3. Jones C,
    4. Baldwin G,
    5. Chou R

    . CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recomm Rep 2022;71:1–95.

    OpenUrl
11. 11.↵
    1. Blanco C,
    2. Kato EU,
    3. Aklin WM,
    4. et al

    . Research to move policy—using evidence to advance health equity for substance use disorders. N Engl J Med 2022;386:2253–5.

    OpenUrl
12. 12.↵
    Economic Research Service USDoA. Rural-urban commuting area codes 2022. Available at: https://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes/.
13. 13.↵
    1. Charlson ME,
    2. Charlson RE,
    3. Peterson JC,
    4. Marinopoulos SS,
    5. Briggs WM,
    6. Hollenberg JP

    . The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. Journal of Clinical Epidemiology 2008;61:1234–40.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Morales ME,
    2. Yong RJ

    . Racial and ethnic disparities in the treatment of chronic pain. Pain Medicine 2020;22:75–90.

    OpenUrl
15. 15.↵
    1. Yan Y,
    2. Yoshihama M,
    3. Hong JS,
    4. Jia F

    . Substance use among Asian American Adults in 2016–2020: a difference-in-difference analysis of a national survey on drug use and health Data. Am J Public Health 2023;113:671–9.

    OpenUrl